Skip to main content
SpringerLink
Log in

Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

GABAergic drugs affect PRL secretion in both rat and man. Sodium valproate (SV) inhibits GABA transaminase so increasing the endogenous GABAergic tone. The aim of this study was to evaluate the effects of SV at low and high doses on PRL release in healthy subjects and hyperprolactinemic patients. Fifteen patients with prolactinomas, 8 patients with non-tumoral hyperprolactinemia and 10 healthy subjects were studied: in non consecutive days, all subjects received placebo and SV at the dose of 400 and 800 mg po. Serum PRL levels were assessed 30, 15 and 5 min before and every 30 min for 4 hours after administration. SV at the dose of 400 mg induced a significant decrease of serum PRL in healthy subjects (p<0.05), whereas no effect was noted in both tumoral and non-tumoral hyperprolactinemia. The administration of 800 mg SV induced a significant decrease of PRL levels in healthy subjects and in patients with non-tumoral hyperprolactinemia (p<0.05). Conversely, in prolactinomas a paradoxical increase of serum PRL concentration (p<0.05) was observed 120 min after the administration of the drug. These data confirm the inhibitory activity of SV on PRL release in healthy subjects, and suggest the existence of a partial resistance to GABA in non-tumoral hyperprolactinemia. In prolactinomas, the paradoxical PRL increase after high dose of SV suggests the existence of a complete pituitary resistance to GABA. This finding might be explained by the appearance of the stimulatory effect of GABA at hypothalamic level that could have been unmasked by the lack of pituitary GABA effects on adenomatous lactotrophs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schally A.V., Redding T.W., Arimura A., Dupont A., Linthicum G.L. Isolation of gamma-aminobutyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro. Endocrinology 100: 681, 1977.

    Article  PubMed  CAS  Google Scholar 

  2. Locatelli V., Cocchi D., Frigerio C., Betti R., Krogsgaard-Larsen P., Racagni G., Muller E.E. Dual γ-aminobutyric acid control of prolactin secretion in the rat. Endocrinology 105: 778, 1979.

    Article  PubMed  CAS  Google Scholar 

  3. Casanueva F., Apud J., Locatelli V., Martinez-Campos A., Civati C., Racagni G., Cocchi D., Muller E.E. Mechanisms subserving the stimulatory and inhibitory components of γ-aminobutyric acid-ergic control of prolactin secretion in the rat. Endocrinology 109: 567, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. Racagni G., Apud J.A., Cocchi D., Locatelli V., Iuliano E., Casanueva F., Muller E.E. Regulation of prolactin secretion during suckling: involvement of the hypothalamo-pituitary GABAergic system. J. Endocrinol. Invest. 7: 481, 1984.

    Article  PubMed  CAS  Google Scholar 

  5. Apud J.A., Masotto C., Racagni G. Effect of THIP and SL 76002, two clinically experimented GABA-mimetic compounds, on anterior pituitary GABA receptors and prolactin secretion in the rat. Life Sci. 40: 871, 1986.

    Article  Google Scholar 

  6. Samuel D., Kumar U., Nieoullon A. γ-aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation? J. Neurochem. 51: 1704, 1988.

    Article  PubMed  CAS  Google Scholar 

  7. Tamminga C.A., Neophytides A., Chase T.N., Frohman L.A. Stimulation of prolactin and growth hormone secretion by Muscimol, a γ-aminobutyric acid agonist. J. Clin. Endocrinol. Metab. 47: 1348, 1978.

    Article  PubMed  CAS  Google Scholar 

  8. Takahara J., Yunoki S., Yakushiji W., Yamauchi J., Yamane Y., Ofuji T. Stimulatory effects of gamma-hydroxybutyric acid on growth and prolactin release in humans. J. Clin. Endocrinol. Metab. 44: 1014, 1977.

    Article  PubMed  CAS  Google Scholar 

  9. Cavagnini F., Invitti C., Di Landro A., Tenconi L., Maraschini C., Girotti G. Effects of a gamma aminobutyric acid (GABA) derivative, baclofen, on growth hormone and prolactin secretion in man. J. Clin. Endocrinol. Metab. 45: 579, 1977.

    Article  PubMed  CAS  Google Scholar 

  10. Melis G.B., Fruzzetti F., Paoletti A.M., Mais V., Beneventi F., Trimarchi G., Fioretti P. Effects of the gabaergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women. Clin. Endocrinol (Oxf.) 20: 245, 1984.

    Article  CAS  Google Scholar 

  11. Debeljuk L., Goijam S., Scilicovich A., Diaz M.C., Rettori V.B. Effect of aminooxyacetic acid and bicuculline on prolactin release in castrated male rats. Life Sci. 27: 2025, 1980.

    Article  PubMed  CAS  Google Scholar 

  12. Melis G.B., Paoletti A.M., Mais V., Fioretti P. Interference of dopamine infusion on γ-aminobutyric acid (GABA)-stimulated prolactin increase. J. Endocrinol. Invest. 4: 445, 1980.

    Article  Google Scholar 

  13. Monteleone P., Maj M., Iovino M., Fiorenza L., Steardo L. Participation of a GABA B binding sites on the control of prolactin, but not gonadotropin secretion in humans. Horm. Metab. Res. 20: 772, 1988.

    Article  PubMed  CAS  Google Scholar 

  14. Racagni G., Apud J.A., Cocchi D., Locatelli V., Muller E.E. Minireview. GABAergic control of anterior pituitary hormone secretion. Life Sci. 31: 823, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Apud J.A., Cocchi D., Locatelli V., Masotto C., Müller E.E., Racagni G. Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABAergic system. Psychoneuroendocrinology 4: 3, 1989.

    Article  Google Scholar 

  16. Loscher W., Schmidt D. Plasma GABA levels in neurological patients under treatment with valproic acid. Life Sci. 28: 2383, 1981.

    Article  Google Scholar 

  17. Melis G.B., Paoletti A.M., Mais V., Mastrapasqua N.M., Strigini F., Fruzzetti F., Guarnieri G., Gambacciani M., Fioretti P. The effects of the Gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects. J. Clin. Endocrinol. Metab. 54: 485, 1982.

    Article  PubMed  CAS  Google Scholar 

  18. Melis G.B., Fruzzetti F., Paoletti A.M., Mais V., Kemeny A., Strigini F., Boldrini A., Fioretti P. Pharmacological activation of γ-aminobutyric acid system blunts prolactin response to mechanical breast stimulation in puerperal women. J. Clin. Endocrinol. Metab. 58: 201, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Guidotti A., Naik S.R., Kurosawa A. Possible role of gamma-aminobutyric acid (GABA) in the regulation of cAMP system in rat anterior pituitary. Psychoneuroendocrinology 2: 227, 1977.

    Article  PubMed  CAS  Google Scholar 

  20. Anderson R., Mitchell R. Distribution of GABA binding subtypes in rat pituitary gland. Brain. Res. 365: 78, 1986.

    Article  PubMed  CAS  Google Scholar 

  21. Felman K., Tappaz M. GABAergic biochemical parameters of the tuberoinfundibular neurons following chronic hyperprolactinemia. Neuroendocrinology 49: 580, 1989.

    Article  PubMed  CAS  Google Scholar 

  22. Felman K., Tappaz M. Evidence for a short feedback of prolactin on tuberoinfundibular endings: differential effect on the release of [3H] gamma-aminobutyric acid and [3H] dopamine from superfused median eminence. J. Neuroendocrinol. 2: 375, 1990.

    Article  PubMed  CAS  Google Scholar 

  23. Grandison L., Guidotti A. Gamma-aminobutyric acid receptor function in rat anterior pituitary: evidence for control of prolactin release. Endocrinology 105: 754, 1979.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Clinical Endocrinology & Oncology, School of Medicine “Federico II” University, Naples, Italy

    F. Sarnacchiaro, A. Colao, B. Merola, A. Di Sarno, M. L. Landi, C. Di Somma, D. Ferone & Gaetano Lombardi M.D.

  2. Institute of Obstetrics and Gynecology, School of Medicine “Federico II” University, Naples, Italy

    A. Tolino

Authors
  1. F. Sarnacchiaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Merola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Di Sarno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. L. Landi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Di Somma
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Ferone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Tolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gaetano Lombardi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarnacchiaro, F., Colao, A., Merola, B. et al. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects. J Endocrinol Invest 20, 513–518 (1997). https://doi.org/10.1007/BF03348012

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348012

Key-words

Search

Navigation